LexaGene Announces Management Cease Trade Order

Author's Avatar
Jun 30, 2022

BEVERLY, Mass., June 30, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”) announces, further to its news release on June 28, 2022, the Company has been granted a management cease trade order (“MCTO”) under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”) imposed against certain insiders of the Company, precluding them from trading securities of the Company. The MCTO will be in effect until the Company’s annual financial statements for the year ended February 28, 2022, its related management’s discussion and analysis and CEO and CFO certifications (collectively, the “Annual Canadian Financial Filings”) are filed on or before August 29, 2022.